Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pas2182
    Junior Member
    • Mar 2012
    • 2

    #1

    Columbia University - postdoctoral position

    A postdoctoral position is available in the laboratory of Peter Sims at Columbia University Medical Center in the Department of Systems Biology. We are located in the Irving Cancer Research Center, a modern and highly collaborative research environment on CUMC's campus in New York City. The lab has established a multi-disciplinary effort to understand the molecular underpinnings of translational regulation in the brain, neurological disorders, and cancer. Multiple projects are available that take advantage of recent advances in next-generation sequencing, microscopy, computational biology, animal models, and procurement of human specimens.

    Candidates must be highly motivated Ph.D.-level scientists with expertise in next-generation sequencing. Experience with translational profiling methods such as ribosome profiling and computational bioinformatic analysis is highly desirable but not essential. Interested candidates should email Dr. Sims directly and include a CV: [email protected].

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...